Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.
Ontology highlight
ABSTRACT: The role of cholesterol in the etiology of Alzheimer's disease (AD) is still controversial. Some studies exploring the association between lipids and/or lipid lowering treatment and AD indicate a harmful effect of dyslipidemia and a beneficial effect of statin therapy on AD risk. The findings are supported by genetic linkage and association studies that have clearly identified several genes involved in cholesterol metabolism or transport as AD susceptibility genes, including apolipoprotein E, apolipoprotein J, and the sortilin-related receptor. Functional cell biology studies support a critical involvement of lipid raft cholesterol in the modulation of amyloid-β protein precursor (AβPP) processing by β- and γ-secretase resulting in altered amyloid-β production. Contradictory evidence comes
SUBMITTER: Reitz C
PROVIDER: S-EPMC3689537 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature
ACCESS DATA